Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance
- Conditions
- DepressionStressInsomniaAnxiety
- Interventions
- Dietary Supplement: Lemon Balm SupplementDietary Supplement: Matched Placebo
- Registration Number
- NCT05602688
- Lead Sponsor
- Ayub Teaching Hospital
- Brief Summary
This study is aimed to investigate if Lemon Balm Extract supplementation is beneficial for the relief of stress, depression and anxiety in healthy adults.
- Detailed Description
Lemon balm (Botanical name: Melissa officinalis L.) is a herbal plant belongs to the Lamiaceae (mint) family, and currently of wide scientific interest as possible adjuvant for calming effect. Lemon balm is one of the most popular and widely used medicinal herbs in central and southern Europe, the Mediterranean region, and west Asia. The European Scientific Cooperative on Phytotherapy (ESCOP) recommends the use of lemon balm to relieve of mild symptoms of anxiety, including mental stress, restlessness, and irritability. Historically, Lemon balm has been widely used in Asian traditional medicine as a sedative to treat many psychiatric disorders, such as stress, depression, anxiety, and insomnia. Lemon balm has shown anti-depressant, anxiolytic, and anti-insomnia effects both in human clinical trials and in animal model studies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 102
- Healthy individuals, aged 18 - 65 years
- Individuals suffering from moderate degree of depression, anxiety, and stress with DASS scores ≥14, ≥10, and ≥19, respectively, or individual with sleep problems with Pittsburgh Sleep Quality Index (PSQI) score ≥5.
- Willing to participate in the study
- Current use of prescribed medication or supplements for neuropsychiatric and sleep disorders
- Known history of neuropsychiatric or sleep disorders
- Current use or history of illicit substances misuse
- History of any allergic reactions to ingredients of the Lemon Balm Extract
- Hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90, or other cardiovascular disease
- Hyperthyroidism or Diabetes mellitus or cancer
- Use of blood thinners like Coumadin (warfarin) or Plavix (clopidogrel), Glaucoma medications like Travatan (travoprost), Chemotherapy drugs like tamoxifen and Camptosar (irinotecan)
- Severe medical problem, which in the opinion of the investigator would pose a safety risk to the subject
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Supplement Group Lemon Balm Supplement This arm will receive oral 200 mg Lemon Balm supplement tablet two times a day for three-weeks. Control group Matched Placebo This arm will receive an oral matched placebo tablet two times a day for three-weeks.
- Primary Outcome Measures
Name Time Method Changes in sleep quality 3 weeks Improvement in the Pittsburgh Sleep Quality Index (PSQI) scale score
Changes in the level of depression 3 weeks Improvement in the Depression score in the Depression Anxiety and Stress Scale (DASS)
Changes in the level of anxiety 3 weeks Improvement in the Anxiety score in the Depression Anxiety and Stress Scale (DASS)
Changes in the level of stress 3 weeks Improvement in the Stress score in the Depression Anxiety and Stress Scale (DASS)
- Secondary Outcome Measures
Name Time Method Changes in Positive and Negative Emotional Feelings 3 weeks Improvement in the Positive and Negative Affect Scale (PANAS) score
Changes in mental wellbeing 3 weeks Improvement in the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) score
Changes in the Quality of Life (QoL) 3 weeks Improvement in the WHO QOL-BREF scale scores
Trial Locations
- Locations (1)
Ayub Teaching Hospital
🇵🇰Abbottābād, Pakistan